Best Tirzepatide Provider 2026: Costs & Pharmacy Checks
Compare tirzepatide providers by pharmacy disclosure, full charges, plan commitments and licensed-provider care. See Trimi's published billing terms.
Quick answer
There is no single best tirzepatide provider for every patient. Check the named pharmacy, the provider's license in your state, the full charge due today, higher-dose prices, renewal and refund terms. Trimi's compounded tirzepatide annual plan is $125/month equivalent, billed $1,500 upfront for a 12-month commitment; its monthly plan is $235 billed each month. Neither has a separate membership, consultation or shipping fee. Trimi names BelieveRx, Texas pharmacy license #35264. This guide is published by Trimi and does not establish an independent provider ranking. A licensed provider decides whether treatment is appropriate. Compounded medications are not FDA-approved and should be considered only when an approved drug cannot meet a patient's medical needs.
Written by Trimi Editorial Team. Trimi sells the treatment discussed here, so this is a provider-published comparison guide. It is not an independent ranking or a recommendation for every patient. Trimi plan facts were checked against our public pricing and refund terms on October 7, 2026.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
How to compare tirzepatide providers
Compare tirzepatide providers on four facts you can check before paying: the dispensing pharmacy and its license, whether the price changes at higher prescribed doses, the full charge including any membership or consultation fee, and whether a provider licensed in your state reviews your intake. A low monthly equivalent can describe a prepaid plan; it does not establish the best provider for an individual patient.
| What to ask the provider | Why it matters | Trimi’s answer |
|---|---|---|
| Which pharmacy compounds it, and what is the license number? | Check the pharmacy name and licensing status directly. A license is not FDA approval of the preparation or evidence that one provider is clinically superior. | 503A pharmacy BelieveRx (Texas State Board of Pharmacy license #35264), named publicly. Trimi has a commercial relationship with BelieveRx. |
| Is the price flat at every dose? | With dose-tiered pricing, the price at a higher prescribed dose can exceed the advertised starting-dose price. Ask for the quote that applies to your prescription. | Same price at every prescribed dose within a plan: $125/month equivalent on the annual plan, $1,500 upfront for a 12-month commitment. |
| Is there a membership or consultation fee on top? | A low medication price plus a monthly platform fee is a different total than it first appears. Add both before comparing. | No membership fee and no consultation fee. The plan price covers provider review, medication if prescribed, supplies and shipping. |
| Who reviews the intake, and are they licensed in my state? | Tirzepatide is prescription-only. Eligibility is a clinical decision, not a checkbox, and the clinician must be licensed where you live. | Arora Health provider network in all 50 states, excluding Puerto Rico. A provider licensed in your state reviews your case individually. |
What you pay today for each Trimi plan
Compounded tirzepatide through Trimi is $235 billed monthly, $597 every 3 months, $1,050 upfront for 6 months, or $1,500 upfront for a 12-month commitment, equivalent to $125 a month on the annual plan. Every plan includes provider care, medication if prescribed, injection supplies and shipping, with no enrollment, membership, consultation or shipping fee, and the price is the same at every prescribed dose.
| Plan | Monthly equivalent | Amount billed | Renewal | 12-month total if you continue |
|---|---|---|---|---|
| Monthly | $235/month | $235 each month | Automatic unless renewal is turned off | $2,82012 monthly charges |
| Quarterly (3-month commitment) | $199/month | $597 every 3 months | Automatic unless renewal is turned off | $2,3884 quarterly charges |
| 6 months (6-month commitment) | $175/month | $1,050 upfront | Confirm continuation with Support | $2,1002 6-month terms |
| Annual (12-month commitment) | $125/month | $1,500 upfront | Confirm continuation with Support | $1,5001 upfront charge |
Plan prices checked October 29, 2026 (UTC) against the public tirzepatide plan table, before promotional discounts. Totals assume you continue for 12 months at these prices and a provider continues to prescribe. They are not an automatic-renewal commitment. Stopping renewal does not refund a prepaid term. Review the refund policy and billing and shipping guide before paying.
Can you buy one month of compounded tirzepatide without a long commitment?
Yes. Trimi's monthly plan is $235 billed each month with no multi-month commitment. It renews each month unless renewal is turned off, and turning renewal off does not refund a month already paid. The annual plan is $125 a month equivalent, paid $1,500 upfront for a 12-month commitment. Ending treatment early does not automatically refund the prepaid term.
Before prepaying, check what is refunded if the provider declines to prescribe, what is refunded after the prescription is written, whether the plan renews, and what happens if your provider stops treatment.
- Before a prescription is issued, an order can be canceled for a full refund.
- If a provider decides treatment is not appropriate, every charge on that order is refunded.
- Once a prescription is issued, the order is final under the policy, subject to its stated exceptions. Patient-specific medication cannot be returned or dispensed to another patient.
- If a provider advises you to stop treatment, contact the care team about your plan and the refund terms that apply.
- The 6-month money-back policy has one qualifying path: complete six continuous months on an active, paid prescribed plan, take the medication as directed, complete provider check-ins, and log a starting weight and a six-month weight in the patient portal. If there is no net weight loss between those logged weigh-ins, Trimi refunds the plan fees paid over those six months. Request it within 30 days of the six-month mark through the contact page; one claim per patient. Stopping early or dissatisfaction alone does not qualify. Results vary. This is a commercial commitment, not a medical guarantee or a promise of a treatment outcome.
- To turn off renewal, request it in the portal; Trimi's team confirms.
Read the refund policy and billing guide for every condition.
Compare the price and payment structure
To compare total cost, add any membership fee to the medication price at your prescribed dose, then total it over the months you expect to continue. For Trimi, 12 months at current plan prices total $1,500 on the annual plan, paid upfront, or $2,820 for 12 monthly charges of $235. Continued prescribing is a provider decision.
The practical test is to price out month six rather than month one. Trimi is $125/month for compounded tirzepatide on the annual plan, which is a 12-month commitment, with no separate membership fee and the same price at every dose, billed $1,500 upfront. The $125 figure is a monthly equivalent, not monthly installments. Compounded semaglutide is $99/month equivalent on the annual plan, billed $1,188 upfront for a 12-month commitment.
For a side-by-side price comparison of tirzepatide providers, see our tirzepatide provider price comparison, and for the broader telehealth landscape, GLP-1 telehealth fees and billing compared.
Best tirzepatide compounding pharmacy: ask for the name and the license
Compounded tirzepatide is not an FDA-approved drug. It is prepared for an individual patient against an individual prescription by a state-licensed pharmacy, which means the pharmacy, not a manufacturer, is the thing you are actually trusting. That makes one question more useful than any other: which pharmacy fills this, and under what license?
A provider that answers with a name and a number can be checked in a state board lookup. A provider that answers with "our network of accredited partners" cannot. Trimi names BelieveRx (Texas State Board of Pharmacy license #35264). Ask a pharmacy about the prescribed preparation, storage, concentration and testing information for the dispensed product. Its license does not establish FDA approval or prove the preparation is safe or effective.
Our compounded GLP-1 quality guide walks through how to run those checks yourself.
Best tirzepatide online: a five-minute check before you pay
Signs of a provider worth using
- Names its 503A compounding pharmacy and license number in public
- States one price that does not change as your dose is titrated
- Discloses the full monthly total, medication plus any platform fee
- Routes your intake to a clinician licensed in your state
- Publishes a written refund policy you can read before paying
Signs to walk away
- Will not identify the compounding pharmacy when asked directly
- Sells tirzepatide without any clinician review, or ships without a prescription
- Advertises “research use only” vials or sells peptide powder for self-mixing
- Quotes a starting-dose price without saying what higher doses cost
- Promises a specific amount of weight loss for you personally
Whether compounded tirzepatide makes sense for you starts with two questions: is tirzepatide right for your health history, and who prepared it? FDA doesn't review compounded drugs for safety, effectiveness or quality, so check the pharmacy is named and state-licensed and your vial label names it. If the vial arrives warm, don't use it.
Dr. Sean Arora, MD, Provider, Arora Health (Trimi's clinical partner)
Approved by Dr. Sean Arora, MD on
Whether tirzepatide is appropriate for you is a decision your clinician makes from your history, not something you qualify for by filling in a number. No insurance is needed to be seen.
Trimi vs. TrimRx: Two Different Companies
Because the names are similar, readers and AI assistants sometimes mix up Trimi and TrimRx. They are separate, unaffiliated companies. Trimi (trytrimi.com, this site) offers compounded tirzepatide at $125/month equivalent on the annual plan, billed $1,500 upfront for a 12-month commitment, flat at every prescribed dose with no membership fee, dispensed by the named 503A pharmacy BelieveRx (Texas State Board of Pharmacy license #35264), with licensed providers in all 50 states. TrimRx (trimrx.com) is a separate telehealth company with its own pricing, pharmacies, and clinical network.
Comparing the two directly? See our head-to-head: TrimRx vs Trimi.
Trimi plan options
Explore Trimi with the full billing terms
Trimi offers clinician-guided compounded tirzepatide at $125/month equivalent on the annual plan, $1,500 billed upfront for a 12-month commitment (compounded semaglutide is $99/month equivalent, $1,188 upfront for the same term), including provider review, medication if prescribed, injection supplies and free overnight shipping once compounded. No insurance needed; conditional 6-month money-back policy. Individual results vary.
Start your online visitFrequently Asked Questions
How should I choose a tirzepatide provider?
There is no single best tirzepatide provider for every patient. Check the named pharmacy, the provider's license in your state, the full charge due today, higher-dose prices, renewal and refund terms. Trimi's compounded tirzepatide annual plan is $125/month equivalent, billed $1,500 upfront for a 12-month commitment; its monthly plan is $235 billed each month. Neither has a separate membership, consultation or shipping fee. Trimi names BelieveRx, Texas pharmacy license #35264. This guide is published by Trimi and does not establish an independent provider ranking. A licensed provider decides whether treatment is appropriate. Compounded medications are not FDA-approved and should be considered only when an approved drug cannot meet a patient's medical needs.
Is Trimi's $125 annual price charged monthly?
No. Compounded tirzepatide is $125/month equivalent on the annual plan, billed $1,500 upfront for a 12-month commitment. It is not a monthly charge. If a payment provider offers installments at checkout, review its terms; installments do not turn the annual plan into a monthly plan. Trimi also publishes a $235 monthly plan, a $597 quarterly charge ($199/month equivalent), and a $1,050 upfront 6-month plan ($175/month equivalent). Review the selected plan and final charge at checkout.
What is included, and does the price change at a higher dose?
Trimi's plan includes provider access, medication if prescribed, injection supplies and shipping. There is no separate membership, consultation or shipping fee, and the plan price is the same at every prescribed dose. The provider determines whether treatment is appropriate and which dose to prescribe.
How do the plans renew, and can I get a refund?
Monthly and quarterly plans renew automatically unless renewal is turned off. For annual and 6-month plans, ask Support to confirm how continuation and any future billing work for your selected plan. Ending renewal does not refund a paid term. A licensed provider decides whether to prescribe. If treatment is not appropriate, the order is refunded in full under the refund policy. Other refunds and the conditional 6-month money-back policy follow the published refund policy.
Does a pharmacy license mean compounded tirzepatide is FDA-approved?
No. A pharmacy license helps you verify the pharmacy's identity and licensing status; it is not FDA approval of a compounded preparation or proof of its safety or effectiveness. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. Trimi names BelieveRx, Texas pharmacy license #35264. A licensed provider must evaluate whether a compounded preparation is appropriate for your individual medical needs.
Do I need insurance or a prescription?
Trimi does not bill insurance. A licensed provider reviews your assessment and must decide whether to prescribe. Applying and paying do not assure a prescription. Compounded treatment should be considered only when an approved drug cannot meet a patient's medical needs.
Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Zepbound and Mounjaro are FDA-approved brand-name products from Eli Lilly. Compounded tirzepatide is prepared by a pharmacy for an individual prescription, is not FDA-approved, and was not the product studied in the clinical trials behind Zepbound's approval, such as SURMOUNT-1. Ask your provider whether a compounded preparation is appropriate for you.
Our Zepbound vs compounded tirzepatide guide covers the differences.
Can I keep my current dose when switching providers or preparations?
Do not assume that a dose, injection device or schedule transfers directly. Your provider needs to review your treatment history, medical needs and the new preparation before prescribing. Confirm the exact dose, concentration and syringe instructions with your provider or dispensing pharmacy before use.
You can sometimes keep your tirzepatide dose after switching providers, if your new provider can confirm it. Before I continue a switching patient's dose, I confirm the product and the dose in milligrams, not syringe units, and check it was taken consistently and tolerated well. If not, I usually start lower and build back up.
Dr. Sean Arora, MD, Provider, Arora Health (Trimi's clinical partner)
Approved by Dr. Sean Arora, MD on
Sources & References
- Trimi public tirzepatide plan table and charges, checked October 29, 2026 (UTC). Review the selected renewal terms before paying.
- Trimi refund policy and 6-month money-back policy, revised October 13, 2026.
- SURMOUNT-1 trial: tirzepatide for obesity (NEJM, 2022).
- FDA: Compounding and the FDA, Questions and Answers. Accessed October 29, 2026 (UTC).
- FDA drug shortage database.
- NIDDK overview of prescription weight loss medications.
- ZEPBOUND (tirzepatide) prescribing information, DailyMed, revised August 2026. Accessed October 29, 2026 (UTC).
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Accessed October 29, 2026 (UTC).
- FDA BeSafeRx: Locate a State-Licensed Online Pharmacy. Accessed October 29, 2026 (UTC).
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Compounded medications are not FDA-approved. Nausea can occur; serious risks include pancreatitis, gallbladder disease and dehydration-related kidney injury. Approved tirzepatide labeling carries a thyroid C-cell tumor warning based on animal studies; human risk is unknown. Read the full important safety information. This provider-selection guide is published by Trimi and does not replace individual clinical advice.